Free Trial

EUDA Health Holdings Limited (NASDAQ:EUDA) Sees Significant Increase in Short Interest

EUDA Health logo with Medical background

EUDA Health Holdings Limited (NASDAQ:EUDA - Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 19,900 shares, an increase of 33.6% from the December 31st total of 14,900 shares. Based on an average daily volume of 86,300 shares, the short-interest ratio is currently 0.2 days. Approximately 0.1% of the company's shares are short sold.

EUDA Health Stock Down 5.3 %

Shares of EUDA stock traded down $0.21 during trading hours on Thursday, reaching $3.70. 100,779 shares of the company traded hands, compared to its average volume of 105,976. The firm has a 50-day moving average price of $4.41 and a 200 day moving average price of $4.20. EUDA Health has a 12-month low of $1.20 and a 12-month high of $6.30.

Analysts Set New Price Targets

Separately, Greenridge Global raised shares of EUDA Health to a "strong-buy" rating in a report on Monday, December 23rd.

Get Our Latest Analysis on EUDA

EUDA Health Company Profile

(Get Free Report)

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUDA Health Right Now?

Before you consider EUDA Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.

While EUDA Health currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines